Minimal residual disease monitoring with high-throughput sequencing of T cell receptors in cutaneous T cell lymphoma

Science Translational Medicine

Volumn 5, Issue 214, 2013, Pages

  Weng, Wen Kai ^a   Armstrong, Randall ^a   Arai, Sally ^a   Desmarais, Cindy ^b   Hoppe, Richard ^a   Kim, Youn H ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ADAPTIVE BIOTECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CUTANEOUS T CELL LYMPHOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA EXTRACTION; FLOW CYTOMETRY; GENE LOCUS; GENE REARRANGEMENT; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; INTERMETHOD COMPARISON; LEUKEMIA REMISSION; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEZARY CELL; TCR BETA GENE;

AGED; BIOPSY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MIDDLE AGED; MYCOSIS FUNGOIDES; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REMISSION INDUCTION; SEZARY SYNDROME; SKIN NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84891685285     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007420     Document Type: Article

References (36)

1. E. Olsen, E. Vonderheid, N. Pimpinelli, Y. Kim, R. Knobler, H. Zackheim, M. Duvic, T. Estrach, S. Lamberg, G. Wood, R. Dummer, A. Ranki, G. Burg, P. Heald, M. Pittelkow, M.-G. Bernengo, W. Sterry, L. Laroche, F. Trautinger, S. Whittaker; ISCL/EORTC, Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: A proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110, 1713-1722 (2007).
2. R. Willemze, E. S. Jaffe, G. Burg, L. Cerroni, E. Berti, S. H. Swerdlow, E. Ralfkiaer, S. Chimenti, J. L. Diaz-Perez, L. M. Duncan, F. Grange, N. L. Harris, W. Kempf, H. Kerl, M. Kurrer, R. Knobler, N. Pimpinelli, C. Sander, M. Santucci, W. Sterry, M. H. Vermeer, J. Wechsler, S. Whittaker, C. J. Meijer, WHO-EORTC classification for cutaneous lymphomas. Blood 105, 3768-3785 (2005).
3. N. Pimpinelli, E. A. Olsen, M. Santucci, E. Vonderheid, A. C. Haeffner, S. Stevens, G. Burg, L. Cerroni, B. Dreno, E. Glusac, J. Guitart, P. W. Heald, W. Kempf, R. Knobler, S. Lessin, C. Sander, B. S. Smoller, G. Telang, S. Whittaker, K. Iwatsuki, E. Obitz, M. Takigawa, M. L. Turner, G. S. Wood; International Society for Cutaneous Lymphoma, Defining early mycosis fungoides. J. Am. Acad. Dermatol. 53, 1053-1063 (2005).
4. H. K. Wong, A. Mishra, T. Hake, P. Porcu, Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome). Br. J. Haematol. 155, 150-166 (2011).
5. Y. H. Kim, H. L. Liu, S. Mraz-Gernhard, A. Varghese, R. T. Hoppe, Long-term outcome of 525 patients with mycosis fungoides and Sézary syndrome: Clinical prognostic factors and risk for disease progression. Arch. Dermatol. 139, 857-866 (2003).
6. F. Vega, R. Luthra, J. Medeiros, V. Dunmire, S. J. Lee, M. Duvic, D. Jones, Clonal heterogeneity in mycosis fungoides and its relationship to clinical course. Blood 100, 3369-3373 (2002).
7. W. G. Morice, J. A. Katzmann, M. R. Oittelkow, R. A. el-Azhary, L. E. Gibson, C. A. Hanson, A comparison of morphologic features, flow cytometry, TCR-V b analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome. Am. J. Clin. Pathol. 125, 364-374 (2006).
8. R. Ponti, P. Quaglino, M. Novelli, M. T. Fierro, A. Comessatti, A. Peroni, L. Bonella, M. G. Bernengo, T-cell receptor g gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: Correlation with clinical, histological and immunophenotypical findings. Br. J. Dermatol. 153, 565-573 (2005).
9. B. Zhang, A. H. Beck, J. M. Taube, S. Kohler, K. Seo, J. Zwerner, N. Viakhereva, U. Sundram, Y. H. Kim, I. Schrijver, D. A. Arber, J. L. Zehnder, Combined use of PCR-based TCRG and TCRB clonality tests on paraffin-embedded skin tissue in the differential diagnosis of mycosis fungoides and inflammatory dermatoses. J. Mol. Diagn. 12, 320-327 (2010).
10. D. N. Posnett, R. Sinha, S. Kabak, C. Russo, Clonal populations of T cells in normal elderly humans: The T cell equivalent to "benign monoclonal gammapathy". J. Exp. Med. 179, 609-618 (1994).
11. R. Talpur, L. Singh, S. Daulat, P. Liu, S. Seyfer, T. Trynosky, W. Wei, M. Duvic, Long-term outcomes of 1,263 patients with mycosis fungoides and Sézary syndrome from 1982 to 2009. Clin. Cancer Res. 18, 5051-5060 (2012).
12. J. J. Scarisbrick, S. Whittaker, A. V. Evans, E. A. Fraser-Andrews, F. J. Child, A. Dean, R. Russell-Jones, Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 97, 624-630 (2001).
13. M. Duvic, M. Donato, B. Dabaja, H. Richmond, L. Singh, W. Wei, S. Acholonu, I. Khouri, R. Champlin, C. Hosing, Total skin electron beam and non-myeloablative allogeneic hematopoietic stemcell transplantation in advanced mycosis fungoides and Sézary syndrome. J. Clin. Oncol. 28, 2365-2372 (2010).
14. R. F. Duarte, C. Canals, F. Onida, I. H. Garbriel, R. Arranz, W. Arcese, A. Ferrant, G. Kobbe, F. Narni, G. L. Deliliers, E. Olavarría, N. Schmitz, A. Sureda, Allogeneic hematopoietic cell transplantation for patients with mycosis fungoides and Sézary syndrome: A retrospective analysis of the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. J. Clin. Oncol. 28, 4492-4499 (2010).
15. V. R. Paralkar, S. D. Nasta, K. Morrissey, J. Smith, P. Vassilev, M. E. Martin, S. C. Goldstein, A. Loren, A. H. Rook, E. J. Kim, D. L. Porter, Allogeneic hematopoietic SCT for primary cutaneous T cell lymphomas. Bone Marrow Transplant. 47, 940-945 (2012).
16. H. S. Robins, S. K. Srivastava, P. V. Campregher, C. J. Turtle, J. Andriesen, S. R. Riddell, C. S. Carlson, E. H. Warren, Overlap and effective size of the human CD8+ T cell receptor repertoire. Sci. Transl. Med. 2, 47ra64 (2010).
17. H. S. Robins, P. V. Campregher, S. K. Srivastava, A. Wacher, C. J. Turtle, O. Kahsai, S. R. Riddell, E. H. Warren, C. S. Carlson, Comprehensive assessment of T-cell receptor b-chain diversity in αβ T cells. Blood 114, 4099-4107 (2009).
18. A. C. Logan, G. Hong, C. Wang, B. Sahaf, C. D. Jones, E. L. Marshall, I. Buño, R. Armstrong, A. Z. Fire, K. I. Weinberg, M. Mindrinos, J. L. Zehnder, S. D. Boyd, W. Xiao, R. W. David, D. B. Miklos, High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc. Natl. Acad. Sci. U.S.A. 108, 21194-21199 (2011).
19. D.Wu, A. Sherwood, J. R. Fromm, S. S. Winter, K. P. Dunsmore, M. L. Loh, H. A. Greisman, D. E. Sabath, B. L. Wood, H. Robins, High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia. Sci. Transl. Med. 4, 134ra63 (2012).
20. J. W. J. can Heijst, I. Ceberio, L. B. Lipuma, D. W. Samilo, G. D. Wasilewski, A. M. R. Gonzales, J. L. Nieves, M. R. M. van den Brink,M. A. Perales, E. G. Pamer, Quantitative assessment of T cell repertoire recovery after hematopoietic stem cell transplantation. Nat. Med. 19, 372-377 (2013).
21. J. J. van Dongen, A. W. Langerak, M. Brüggemann, P. A. S. Evans, M. Hummel, F. L. Lavender, E. Delabesse, F. Davi, E. Schuuring, R. García-Sanz, J. H. J. M. van Krieken, J. Droese, D. González, C. Bastard, H. E. White, M. Spaargaren, M. González, A. Parreira, J. L. Smith, G. J. Morgan, M. Kneba, E. A. Macintyre, Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17, 2257-2317 (2003).
22. C. D. Klemke, J. Brade, S. Weckesser, M. M. Sachse, N. Booken, M. Neumaier, S. Goerdt, T. C. Nebe, The diagnosis of Sézary syndrome on peripheral blood by flow cytometry requires the use of multiple markers. Br. J. Dermatol. 159, 871-880 (2008). Downloaded from stm.sciencemag.org on December 28, 2013
23. E. A. Olsen, S. Whittaker, Y. H. Kim, M. Duvic, H. M. Prince, S. R. Lessin, G. S. Wood, R. Willemze, M. F. Demierre, N. Pimpinelli, M. G. Bernengo, P. L. Ortiz-Romero, M. Bagot, T. Estrach, J. Guitart, R. Knobler, J. A. Sanches, K. Iwatsuki, M. Sugaya, R. Dummer, M. Pittelkow, R. Hoppe, S. Parker, L. Geskin, L. Pinter-Brown, M. Girardi, G. Burg, A. Ranki, M. Vermeer, S. Horwitz, P. Heald, S. Rosen, L. Cerroni, B. Dreno, E. C. Vonderheid; International Society for Cutaneous Lymphomas; United States Cutaneous Lymphoma Consortium; Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer, Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: A consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J. Clin. Oncol. 29, 2598-2607 (2011).
24. S. E. Thurber, B. Zhang, Y. H. Kim, I. Schrijver, J. Zehnder, S. Kohler, T-cell clonality analysis in biopsy specimens from two different skin sites shows high specificity in the diagnosis of patients with suggested mycosis fungoides. J. Am. Acad. Dermatol. 57, 782-790 (2007).
25. B. Feng, J. L. Jorgensen, D. Jones, S. S. Chen, Y. Hu, L. J. Medeiros, S. A. Wang, Flow cytometric detection of peripheral blood involvement by mycosis fungoides and Sézary syndrome using T-cell receptor Vb chain antibodies and its application in blood staging. Mod. Pathol. 23, 284-295 (2010).
26. D. Billadeau, M. Blackstadt, P. Greipp, R. A. Kyle, M. M. Oken, N. Kay, B. Van Ness, Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: A technique for sequential quantitation of residual disease. Blood 78, 3021-3029 (1991).
27. V. H. van der Velden, A. Hochhaus, G. Cazzaniga, T. Szczepanski, J. Gabert, J. J. M. van Dongen, Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: Principles, approaches, and laboratory aspects. Leukemia 17, 1013-1034 (2003).
28. V. H. van der Velden, G. Cazzaniga, A. Schrauder, J. Hancock, P. Bader, E. R. Panzer-Grumayer, T. Flohr, R. Sutton, H. Cave, H. O. Madsen, J. M. Cayuela, J. Trka, C. Eckert, L. Foroni, U. Zur Stadt, K. Beldjord, T. Raff, C. E. van der Schoot, J. J. van Dongen; European Study Group on MRD detection in ALL (ESG-MRD-ALL), Analysis of minimal residual disease by Ig/TCR gene rearrangements: Guidelines for interpretation of real-time quantitative PCR data. Leukemia 21, 604-611 (2007).
29. B. K. Zehentner, W. Fritschle, T. Stelzer, K. M. Ghirardelli, K. Hunter, C. Wentzel, R. Bennington, C. L. Hansen, D. Myerson, M. Kalnoski, D. A. Wells, M. R. Loken, Minimal disease detection and confirmation in hematologic malignancies: Combining cell sorting with clonality profiling. Clin. Chem. 52, 430-437 (2006).
30. A. C. Logan, B. Zhang, B. Narasimhan, V. Carlton, J. Zheng, M. Moorhead, M. R. Krampf, C. D. Jones, A. N. Wagar, M. Faham, J. L. Zehnder, D. B. Miklos, Minimal residual disease quantification using consensus primers and high-throughput IGH sequencing predicts post-transplant relapse in chronic lymphocytic leukemia. Leukemia 27, 1659-1665 (2013).
31. E. H.Meyer, A. R. Hsu, J. Liliental, A. Löhr, M. Florek, J. L. Zehnder, S. Strober, P. Lavori, D. B.Miklos, D. S. Johnston, R. S. Negrin, A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease. Blood 121, 4955-4962 (2013).
32. S. Böttcher, M. Ritgen, P. Dreger, Allogeneic stem cell transplantation for chronic lymphocytic leukemia: Lessons to be learned from minimal residual disease studies. Blood Rev. 25, 91-96 (2011).
33. V. Conter, C. R. Bartram, M. G. Valsecchi, A. Schrauder, R. Ranzer-Grümayer, A. Möricke, M. Aricò, M. Zimmermann, G. Mann, G. De Rossi, M. Stanulla, F. Locatelli, G. Basso, F. Niggli, E. Barisone, G. Henze, W. D. Ludwig, O. A. Haas, G. Cazzaniga, R. Koehler, D. Silvestri, J. Bradtke, R. Parasole, R. Beier, J. J. M. van Dongen, A. Biondi, M. Schrappe, Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: Results in 3184 patients of the AIEOP-BFMALL 2000 study. Blood 115, 3206-3214 (2010).
34. N. S. Agar, E. Wedgeworth, S. Crichton, T. J. Mitchell, M. Cox, S. Ferreira, A. Robson, E. Calonje, C. M. Stefanato, E. M. Wain, B. Wilkins, P. A. Fields, A. Dean, K. Webb, J. Scarisbrick, S. Morris, S. J. Whittaker, Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: Validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal. J. Clin. Oncol. 28, 4730-4739 (2010).
35. D. Jone, N. H. Dang, M. Duvic, L. T. Washington, Y. O. Huh, Absence of CD26 expression is a useful marker for diagnosis of T-cell lymphoma in peripheral blood. Am. J. Clin. Pathol. 115, 885-892 (2001).
36. K. Kelemen, J. Guitart, T. M. Kuzel, C. L. Goolsby, L. C. Peterson, The usefulness of CD26 in flow cytometric analysis of peripheral blood in Sézary syndrome. Am. J. Clin.Pathol. 129, 146-156 (2008).